NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals
Details
- Buyer
- NHS England
- Supplier(s)
50 suppliers
- AVENTIS PHARMA LIMITED
- Accord UK Ltd
- Aspen Pharmacare UK Limited
- Aspire Pharma Ltd
- Astellas Pharma LTD.
- Bayer Public Limited Company
- Chiesi Ltd
- CST Pharma Limited
- Day Lewis Medical Ltd
- Dexcel Pharma Ltd
- DRUGSRUS LIMITED
- Eli Lilly and Company Ltd
- Ferring Pharmaceutical
- GEDEON RICHTER (UK) LIMITED
- Gerot Lannach UK Ltd
- Glenmark Pharmaceuticals Europe Ltd
- Ipsen
- Janssen Cilag Ltd
- Kent Pharma Ltd
- Lupin Healthcare (UK) Ltd
- Martindale Pharma
- medac Pharma LLP
- Merck Serono Limited
- Mercury Pharmaceuticals Ltd
- Morningside Pharmaceuticals Ltd
- Mylan
- Napp Pharmaceuticals Ltd
- Neuraxpharm UK Ltd
- Nordic Pharma Ltd
- Norgine Pharmaceuticals Limited
- Novartis Pharmaceutical UK Ltd
- Orifarm UK
- Otsuka Pharmaceuticals UK Limited
- Pfizer Liimted
- Pharmasure
- Qdem Pharmaceuticals
- Recordati Rare Diseases UK Ltd
- Ridge Pharma
- ROVI BIOTECH LIMITED
- Sandoz
- Selective Supplies Ltd
- Synchrony
- Takeda UK Limited
- Tetris Pharma Lts
- Teva UK Ltd
- Theramex HQ UK Ltd
- Tillomed Laboratories Ltd
- Wockhardt UK Limited
- Xiromed
- Zentiva Pharma UK Ltd
- Value
- GBP 304,504,000
- Duration
- 2 years
- Topic
- Pharmaceutical products
- Published
- 6 April 2023
- Source
- uk:contracts_finder
Tender description
NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals Offer reference number: CM/PHR/22/5675 CM/PHR/22/5675/01 - NHS Framework Agreement for Branded Medicines - National Category Tender Lot 1. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines - National Tender Lot 2. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
Timeline
- Completed: Award published6 April 2023Current notice
- Completed: Award date1 May 2023
- Completed: Contract expiry date30 April 2025
About the buyer
NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
6 similar open tenders
See more open tenders related to NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS England.
- 461£2.1bn
- 372£250.0m
- 364£15.0bn
- 294£2.8bn
- 267£19.9bn
- 265£902.8m
- 253£515.5m
- 203£1.0bn
- 142£900.0m
- 126£60.5m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
